IL6 and chronic obstructive pulmonary disease: This integration is demonstrated by Buzhong Yiqi Decoction: vMOC validation of its “lung-spleen axis” mechanism identified IL-6/TNF-α as clinical biomarkers, enabling successful repurposing for COPD (Yi-Ling et al., 2020).